A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

CLDX Insider Trading (Celldex Therapeutics)

Insider Ownership Percentage: 2.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,463,359.00

Celldex Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Celldex Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Celldex Therapeutics Share Price & Price History

Current Price: $37.33
Price Change: Price Increase of +2.8 (8.11%)
As of 08/12/2022 01:00 AM ET

This chart shows the closing price history over time for CLDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

Celldex Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/23/2021Samuel Bates MartinCFOSell9,500$42.00$399,000.00View SEC Filing Icon  
12/8/2021Elizabeth CrowleyVPSell4,000$40.00$160,000.00View SEC Filing Icon  
12/8/2021Sarah B. CavanaughSVPSell7,323$40.00$292,920.00View SEC Filing Icon  
11/15/2021Samuel Bates MartinCFOSell9,500$43.57$413,915.00View SEC Filing Icon  
11/12/2021Diane C. YoungSVPSell4,600$42.94$197,524.00View SEC Filing Icon  
8/11/2021Freddy A. JimenezSVPBuy430$46.28$19,900.40430View SEC Filing Icon  
8/10/2021Samuel Bates MartinCFOSell2,738$45.25$123,894.50View SEC Filing Icon  
12/14/2020Richard M. WrightVPSell20,832$18.61$387,683.52View SEC Filing Icon  
6/11/2020Diane C. YoungSVPBuy2,115$4.73$10,003.952,115View SEC Filing Icon  
6/9/2020Anthony S. MarucciCEOBuy15,000$2.99$44,850.00View SEC Filing Icon  
6/9/2020James J MarinoDirectorBuy8,305$2.99$24,831.9512,704View SEC Filing Icon  
6/9/2020Margo Heath-ChiozziSVPBuy1,000$2.99$2,990.001,000View SEC Filing Icon  
6/9/2020Samuel Bates MartinCFOBuy9,750$2.99$29,152.50View SEC Filing Icon  
6/9/2020Tibor KelerVPBuy5,000$2.99$14,950.007,357View SEC Filing Icon  
See Full Table
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

SEC Filings (Institutional Ownership Changes) for Celldex Therapeutics (NASDAQ:CLDX)

98.61% of Celldex Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CLDX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Celldex Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/13/2022Zurcher Kantonalbank Zurich Cantonalbank 3,783$0.10M0.0%-32.6%0.008%Search for SEC Filing on Google Icon
8/13/2022American International Group Inc.21,449$0.58M0.0%-6.1%0.046%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp423,667$11.42M0.0%-3.6%0.906%Search for SEC Filing on Google Icon
8/12/2022Virtus ETF Advisers LLC4,816$0.13M0.0%+16.6%0.010%Search for SEC Filing on Google Icon
8/12/2022Credit Suisse AG29,907$0.81M0.0%+3.4%0.064%Search for SEC Filing on Google Icon
8/12/2022Rafferty Asset Management LLC123,806$3.34M0.0%-20.8%0.265%Search for SEC Filing on Google Icon
8/12/2022FMR LLC7,013,144$189.07M0.0%+0.0%14.995%Search for SEC Filing on Google Icon
8/12/2022BNP Paribas Arbitrage SA9,906$0.27M0.0%+162.0%0.021%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers64,958$1.75M0.0%+24.4%0.139%Search for SEC Filing on Google Icon
8/11/2022Deutsche Bank AG170,214$4.59M0.0%+127.4%0.364%Search for SEC Filing on Google Icon
8/11/2022Alps Advisors Inc.27,740$0.75M0.0%N/A0.059%Search for SEC Filing on Google Icon
8/11/2022JPMorgan Chase & Co.42,346$1.14M0.0%+21.4%0.091%Search for SEC Filing on Google Icon
8/10/2022Principal Financial Group Inc.8,638$0.23M0.0%-79.7%0.018%Search for SEC Filing on Google Icon
8/10/2022WINTON GROUP Ltd8,322$0.22M0.0%N/A0.018%Search for SEC Filing on Google Icon
8/5/2022Mirador Capital Partners LP106,368$2.87M0.7%+18.1%0.228%Search for SEC Filing on Google Icon
8/4/2022TD Asset Management Inc.36,661$0.99M0.0%-50.3%0.078%Search for SEC Filing on Google Icon
8/3/2022Candriam S.C.A.290,794$7.84M0.1%+4.8%0.622%Search for SEC Filing on Google Icon
8/1/2022Victory Capital Management Inc.18,687$0.50M0.0%+7.2%0.040%Search for SEC Filing on Google Icon
7/29/2022SG Americas Securities LLC55,755$1.50M0.0%+299.4%0.119%Search for SEC Filing on Google Icon
7/26/2022Mirae Asset Global Investments Co. Ltd.13,749$0.37M0.0%N/A0.029%Search for SEC Filing on Google Icon
7/25/2022Allspring Global Investments Holdings LLC2,403$64K0.0%-89.8%0.005%Search for SEC Filing on Google Icon
7/21/2022TSP Capital Management Group LLC266,545$7.19M2.8%-0.9%0.570%Search for SEC Filing on Google Icon
6/30/2022Amalgamated Bank7,080$0.24M0.0%-7.3%0.015%Search for SEC Filing on Google Icon
6/7/2022Teachers Retirement System of The State of Kentucky32,242$1.10M0.0%+44.1%0.069%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE180,894$6.16M0.0%+91.5%0.387%Search for SEC Filing on Google Icon
6/2/2022Verition Fund Management LLC87,230$2.97M0.0%+62.0%0.187%Search for SEC Filing on Google Icon
5/27/2022Walleye Capital LLC37,381$1.27M0.0%+162.7%0.080%Search for SEC Filing on Google Icon
5/20/2022The Manufacturers Life Insurance Company 63,511$2.19M0.0%+172.7%0.136%Search for SEC Filing on Google Icon
5/18/2022BNP Paribas Arbitrage SA3,781$0.13M0.0%-74.1%0.008%Search for SEC Filing on Google Icon
5/17/2022Walleye Capital LLC37,381$1.27M0.0%+162.7%0.080%Search for SEC Filing on Google Icon
5/17/2022Kiwi Wealth Investments Limited Partnership27,477$0.94M0.1%-47.1%0.059%Search for SEC Filing on Google Icon
5/17/2022Point72 Hong Kong Ltd1,394$47K0.0%+57.9%0.003%Search for SEC Filing on Google Icon
5/17/2022Polar Asset Management Partners Inc.69,200$2.36M0.0%N/A0.148%Search for SEC Filing on Google Icon
5/17/2022Polar Capital Holdings Plc1,250,000$42.58M0.2%+25.0%2.674%Search for SEC Filing on Google Icon
5/17/2022RA Capital Management L.P.2,075,000$70.68M1.5%+15.0%4.439%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada2,829$96K0.0%-70.4%0.006%Search for SEC Filing on Google Icon
5/17/2022RTW Investments LP3,084,215$105.05M2.2%-21.4%6.597%Search for SEC Filing on Google Icon
5/17/2022Rock Springs Capital Management LP97,317$3.32M0.1%N/A0.208%Search for SEC Filing on Google Icon
5/17/2022Sessa Capital IM L.P.212,000$7.22M0.3%N/A0.453%Search for SEC Filing on Google Icon
5/17/2022Eventide Asset Management LLC1,445,700$49.24M0.8%+16.7%3.092%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System51,457$1.75M0.0%-8.9%0.110%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.303,419$10.34M0.0%+19.4%0.649%Search for SEC Filing on Google Icon
5/16/2022Viking Global Investors LP1,846,647$62.90M0.3%+143.7%3.950%Search for SEC Filing on Google Icon
5/16/2022Woodline Partners LP579,192$19.73M0.3%+122.9%1.239%Search for SEC Filing on Google Icon
5/16/2022Wellington Management Group LLP3,529,840$120.23M0.0%+61.5%7.550%Search for SEC Filing on Google Icon
5/16/2022State Street Corp2,682,728$91.37M0.0%+13.3%5.738%Search for SEC Filing on Google Icon
5/16/2022Eversept Partners LP636,453$21.68M1.8%+7.4%1.361%Search for SEC Filing on Google Icon
5/16/2022Engineers Gate Manager LP7,086$0.24M0.0%N/A0.015%Search for SEC Filing on Google Icon
5/16/2022Ghost Tree Capital LLC300,000$10.22M2.2%-14.3%0.642%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.18,123$0.62M0.0%-91.3%0.039%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG160,779$5.48M0.0%+23.1%0.344%Search for SEC Filing on Google Icon
5/13/2022Silverarc Capital Management LLC45,538$0.26M0.1%+0.9%0.097%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp439,534$14.97M0.0%-5.3%0.940%Search for SEC Filing on Google Icon
5/13/2022Verition Fund Management LLC87,230$2.97M0.0%+62.0%0.187%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.336,808$11.47M0.0%+2.7%0.720%Search for SEC Filing on Google Icon
5/13/2022Affinity Asset Advisors LLC125,000$4.26M0.7%+25.0%0.267%Search for SEC Filing on Google Icon
5/13/2022First Trust Advisors LP52,773$1.80M0.0%-48.2%0.113%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.22,831$0.78M0.0%-6.6%0.049%Search for SEC Filing on Google Icon
5/13/2022Ergoteles LLC11,702$0.40M0.0%-27.6%0.025%Search for SEC Filing on Google Icon
5/13/2022DLD Asset Management LP7,700$0.26M0.0%N/A0.016%Search for SEC Filing on Google Icon
5/13/2022Candriam Luxembourg S.C.A.277,481$9.45M0.1%-28.3%0.594%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.2,433,595$82.89M0.0%+0.9%5.206%Search for SEC Filing on Google Icon
5/13/2022Kynam Capital Management LP753,034$25.65M8.3%+232.1%1.611%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP592,358$20.18M0.0%+31.8%1.267%Search for SEC Filing on Google Icon
5/12/2022TSP Capital Management Group LLC269,045$9.16M3.1%+6.1%0.575%Search for SEC Filing on Google Icon
5/12/2022Gyon Technologies Capital Management LP10,552$0.36M0.3%-42.6%0.023%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.3,046,822$103.77M0.0%-1.7%6.517%Search for SEC Filing on Google Icon
5/12/2022Rhumbline Advisers52,219$1.78M0.0%+4.8%0.112%Search for SEC Filing on Google Icon
5/12/2022Metropolitan Life Insurance Co NY2,996$0.10M0.0%-75.3%0.006%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC25,208$0.86M0.0%+57.0%0.054%Search for SEC Filing on Google Icon
5/12/2022E Fund Management Co. Ltd.7,838$0.27M0.0%N/A0.017%Search for SEC Filing on Google Icon
5/12/2022HighTower Advisors LLC10,218$0.35M0.0%N/A0.022%Search for SEC Filing on Google Icon
5/11/2022American Century Companies Inc.183,017$6.23M0.0%-0.8%0.391%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.34,888$1.19M0.0%-365.0%0.075%Search for SEC Filing on Google Icon
5/11/2022GMT Capital Corp204,535$6.97M0.4%N/A0.437%Search for SEC Filing on Google Icon
5/10/2022ProShare Advisors LLC8,628$0.29M0.0%-14.1%0.018%Search for SEC Filing on Google Icon
5/10/2022TD Asset Management Inc.73,829$2.52M0.0%+18.5%0.158%Search for SEC Filing on Google Icon
5/9/2022Campbell & CO Investment Adviser LLC8,692$0.30M0.1%+14.4%0.019%Search for SEC Filing on Google Icon
5/9/2022Principal Financial Group Inc.42,489$1.45M0.0%-26.2%0.091%Search for SEC Filing on Google Icon
5/9/2022Swiss National Bank88,200$3M0.0%+7.7%0.189%Search for SEC Filing on Google Icon
5/9/2022Teacher Retirement System of Texas7,745$0.26M0.0%+8.3%0.017%Search for SEC Filing on Google Icon
5/6/2022HC Advisors LLC7,675$0.26M0.2%-6.2%0.016%Search for SEC Filing on Google Icon
5/6/2022Mirador Capital Partners LP90,048$3.07M0.6%+4.6%0.193%Search for SEC Filing on Google Icon
5/4/2022ClariVest Asset Management LLC16,400$0.56M0.0%-12.3%0.035%Search for SEC Filing on Google Icon
5/4/2022Prospera Financial Services Inc2,622$89K0.0%N/A0.006%Search for SEC Filing on Google Icon
5/4/2022Victory Capital Management Inc.17,424$0.53M0.0%+12.5%0.037%Search for SEC Filing on Google Icon
4/29/2022SG Americas Securities LLC13,960$0.48M0.0%+38.4%0.030%Search for SEC Filing on Google Icon
4/29/2022Nisa Investment Advisors LLC1,390$47K0.0%-37.2%0.003%Search for SEC Filing on Google Icon
4/21/2022Zurcher Kantonalbank Zurich Cantonalbank5,610$0.19M0.0%+35.1%0.012%Search for SEC Filing on Google Icon
3/3/2022Walleye Capital LLC14,227$0.55M0.0%N/A0.030%Search for SEC Filing on Google Icon
2/25/2022AlphaCentric Advisors LLC17,000$0.66M0.2%N/A0.036%Search for SEC Filing on Google Icon
2/23/2022Barclays PLC139,952$5.41M0.0%+251.9%0.300%Search for SEC Filing on Google Icon
2/19/2022Woodline Partners LP259,895$10.04M0.1%N/A0.557%Search for SEC Filing on Google Icon
2/16/2022Ghost Tree Capital LLC350,000$13.52M4.8%+37.3%0.750%Search for SEC Filing on Google Icon
2/16/2022SG3 Management LLC17,500$0.68M0.0%-67.9%0.038%Search for SEC Filing on Google Icon
2/15/2022Sofinnova Investments Inc.271,533$10.49M0.6%+98.2%0.582%Search for SEC Filing on Google Icon
2/15/2022Kennedy Capital Management Inc.28,158$1.09M0.0%N/A0.060%Search for SEC Filing on Google Icon
2/15/2022Adage Capital Partners GP L.L.C.650,000$25.12M0.0%-31.6%1.393%Search for SEC Filing on Google Icon
2/14/2022Canada Pension Plan Investment Board23,600$0.91M0.0%+114.5%0.051%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC16,327$0.63M0.0%N/A0.035%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Celldex Therapeutics logo
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity; CDX-1140, a human agonist monoclonal antibody targeted to CD40, a key activator of immune response, which is found on dendritic cells, macrophages, and B cells, as well as is expressed on various cancer cells; and CDX-527, a bispecific antibody, which uses the company's proprietary active anti-PD-L1 and CD27 human antibodies to couple CD27 costimulation with blockade of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses through CD27 costimulation. The company has research collaboration and license agreements with University of Southampton to develop human antibodies towards CD27; Amgen Inc. with exclusive rights to CDX-301 and CD40 ligand; and Yale University. Celldex Therapeutics, Inc. was incorporated in 1983 and is headquartered in Hampton, New Jersey.
Read More on Celldex Therapeutics

Today's Range

Now: $37.33
Low: $34.31
High: $37.98

50 Day Range

MA: $27.91
Low: $20.50
High: $37.47

52 Week Range

Now: $37.33
Low: $19.85
High: $57.20

Volume

582,593 shs

Average Volume

563,335 shs

Market Capitalization

$1.75 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.43

Who are the company insiders with the largest holdings of Celldex Therapeutics?

Celldex Therapeutics' top insider investors include:
  1. Freddy A Jimenez (SVP)
  2. Diane C Young (SVP)
  3. Elizabeth Crowley (VP)
  4. Richard M Wright (VP)
  5. Samuel Bates Martin (CFO)
  6. Sarah Cavanaugh (SVP)
Learn More about top insider investors at Celldex Therapeutics.

Who are the major institutional investors of Celldex Therapeutics?

Celldex Therapeutics' top institutional investors include:
  1. FMR LLC — 14.99%
  2. Ikarian Capital LLC — 0.00%
  3. Northern Trust Corp — 0.91%
  4. Candriam S.C.A. — 0.62%
  5. TSP Capital Management Group LLC — 0.57%
  6. Deutsche Bank AG — 0.36%
Learn More about top institutional investors of Celldex Therapeutics stock.

Which institutional investors are selling Celldex Therapeutics stock?

During the previous quarter, CLDX stock was sold by these institutional investors:
  1. TD Asset Management Inc.
  2. Principal Financial Group Inc.
  3. Rafferty Asset Management LLC
  4. Allspring Global Investments Holdings LLC
  5. Walleye Trading LLC
  6. Northern Trust Corp
  7. TSP Capital Management Group LLC
  8. Zurcher Kantonalbank Zurich Cantonalbank
During the previous year, company insiders that have sold Celldex Therapeutics company stock include:
  1. Freddy A Jimenez (SVP)
  2. Diane C Young (SVP)
  3. Elizabeth Crowley (VP)
  4. Richard M Wright (VP)
Learn More investors selling Celldex Therapeutics stock.

Which institutional investors are buying Celldex Therapeutics stock?

During the previous quarter, CLDX stock was purchased by institutional investors including:
  1. Deutsche Bank AG
  2. SG Americas Securities LLC
  3. DLD Asset Management LP
  4. Silverarc Capital Management LLC
  5. Alps Advisors Inc.
  6. Simplex Trading LLC
  7. Group One Trading L.P.
  8. Ikarian Capital LLC
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.